Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $57M (100.0% shares, 0.0% debt)

Holdings (17)

— Corbus Pharmaceuticals HLDGS 38.0%

Value $21.66M Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Abeona Therapeutics Inc 20.1%

Value $11.45M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Vascular Biogenics LTD 7.3%

Value $4.174M Shares 860,605 Est. Cost $4.61 Unrealized —

AVXL Anavex Life Sciences Corp 5.0%

Value $2.868M Shares 724,205 Est. Cost $3.56 Unrealized 0.0%

— Ritter Pharmaceuticals, Inc 4.5%

Value $2.581M Shares 952,434 Est. Cost $2.12 Unrealized —

— Alcobra Ltd 4.4%

Value $2.532M Shares 1,205,498 Est. Cost $6.71 Unrealized —

— Ampio Pharmaceuticals Inc. 4.4%

Value $2.492M Shares 2,738,322 Est. Cost $6.03 Unrealized —

VNRX Volition RX LTD 3.7%

Value $2.091M Shares 461,538 Est. Cost $3.75 Unrealized +19.5%

— Advaxis Inc. 2.8%

Value $1.611M Shares 225,000 Est. Cost $7.16 Unrealized —

— Synthetic Biologics Inc. 2.7%

Value $1.553M Shares 2,034,949 Est. Cost $1.55 Unrealized —

— Keryx Biopharmaceuticals Inc. 2.1%

Value $1.172M Shares 200,000 Est. Cost $10.21 Unrealized —

— Newlink Genetics Corp 1.7%

Value $962K Shares 93,533 Est. Cost $27.98 Unrealized —

ALDX Aldeyra Therapeutics Inc 1.3%

Value $727K Shares 135,800 Est. Cost $10.20 Unrealized -42.5%

— Advaxis Inc. 0.8%

Value $446K Shares 112,500 Est. Cost $3.96 Unrealized —

— OHR Pharmaceutical Inc 0.5%

Value $306K Shares 204,137 Est. Cost $2.54 Unrealized —

— Bio Blast Pharma Ltd 0.4%

Value $214K Shares 206,054 Est. Cost $7.27 Unrealized —

— Caladrius Biosciences Inc 0.3%

Value $157K Shares 55,579 Est. Cost $2.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	2,563,925	$21.66M	38.0%	$2.53	—	COM	21833P103
—	Abeona Therapeutics Inc	2,359,767	$11.45M	20.1%	$4.97	—	COM	00289Y107
—	Vascular Biogenics LTD	860,605	$4.174M	7.3%	$4.61	—	COM	M96883109
AVXL	Anavex Life Sciences Corp	724,205	$2.868M	5.0%	$3.56	0.0%	COM NEW	032797300
—	Ritter Pharmaceuticals, Inc	952,434	$2.581M	4.5%	$2.12	—	COM	767836109
—	Alcobra Ltd	1,205,498	$2.532M	4.4%	$6.71	—	SHS	M2239P109
—	Ampio Pharmaceuticals Inc.	2,738,322	$2.492M	4.4%	$6.03	—	COM	03209T109
VNRX	Volition RX LTD	461,538	$2.091M	3.7%	$3.75	+19.5%	COM	928661107
—	Advaxis Inc.	225,000	$1.611M	2.8%	$7.16	—	COM NEW	007624208
—	Synthetic Biologics Inc.	2,034,949	$1.553M	2.7%	$1.55	—	COM	87164U102
—	Keryx Biopharmaceuticals Inc.	200,000	$1.172M	2.1%	$10.21	—	COM	492515101
—	Newlink Genetics Corp	93,533	$962K	1.7%	$27.98	—	COM	651511107
ALDX	Aldeyra Therapeutics Inc	135,800	$727K	1.3%	$10.20	-42.5%	COM	01438T106
—	Advaxis Inc.	112,500	$446K	0.8%	$3.96	—	W EXP 07/15/201	007624117
—	OHR Pharmaceutical Inc	204,137	$306K	0.5%	$2.54	—	COM NEW	67778H200
—	Bio Blast Pharma Ltd	206,054	$214K	0.4%	$7.27	—	SHS	M20156101
—	Caladrius Biosciences Inc	55,579	$157K	0.3%	$2.82	—	COM NEW	128058203